Yu T, Yang C, Li M. Comment on "Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases". Br J Cancer 2024 Feb 20. doi: 10.1038/s41416-024-02616.
PMID: 38378876